Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study.

Fariña-Sarasqueta A, van Lijnschoten G, Rutten HJ, van den Brule AJ

Open source

DOI
10.1007/s00280-010-1403-0
Published
2010 Nov
Container
Cancer chemotherapy and pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-010-1403-0,
  title = {Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study.},
  author = {Fariña-Sarasqueta A and van Lijnschoten G and Rutten HJ and van den Brule AJ},
  year = {2010},
  journal = {Cancer chemotherapy and pharmacology},
  doi = {10.1007/s00280-010-1403-0},
  url = {https://doi.org/10.1007/s00280-010-1403-0}
}

RIS

TY  - JOUR
TI  - Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study.
AU  - Fariña-Sarasqueta A
AU  - van Lijnschoten G
AU  - Rutten HJ
AU  - van den Brule AJ
PY  - 2010
JO  - Cancer chemotherapy and pharmacology
DO  - 10.1007/s00280-010-1403-0
UR  - https://doi.org/10.1007/s00280-010-1403-0
ER  - 

APA

A, F., G, V. L., HJ, R., & AJ, V. D. B. (2010). Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-010-1403-0

Source records